Diabetes technology

Efficacy and safety of hybrid closed-loop systems in children aged < 7 years with type 1 diabetes: a systematic review and meta-analysis of randomized controlled trials

Pediatr DiabetesPublished Systematic review and meta-analysis of randomised controlled trials

Pooled result · Percentage of time in rangeResult — go to the resultMD 9.95 % 95% CI 7.8–12.09

Authors' conclusion

The hybrid closed-loop system can effectively improve glycemic control in children under 7 years old with Type 1 diabetes without increasing the risk of adverse events.

Study context

Population
Children aged <7 years with T1D; PubMed, Cochrane Library, Embase, Web of Science to July 30, 2025
Participants
274 children3 RCTs
Comparison
Hybrid closed-loop system vs conventional therapy
Outcome
Percentage of time in range
Follow-up
3 months
Methodological detailsTwo investigators independently screened, extracted data and assessed risk of bias; meta-analysis in RevMan 5.4
  • Two investigators independently screened, extracted data and assessed risk of bias; meta-analysis in RevMan 5.4

Pooled result

As reported in the abstract

MD

9.95 %

95% CI 7.8–12.09

P < 0.00001

Hybrid closed-loop systemvs Conventional therapy
MD 9.95 % (95% CI 7.8–12.09); P < 0.00001

Further pooled results

OutcomeMD (%) (95% CI)P value
HbA1c · 3 months−0.51 (−0.64 to −0.37)P < 0.00001
Percentage of time below range0.56 (−0.13 to 1.25)P = 0.11

Safety

OutcomeP value
Serious adverse events: DKA and severe hypoglycaemiaHybrid closed-loop system vs Conventional therapyP = 0.50
Serious adverse events: DKA and severe hypoglycaemiaHybrid closed-loop system vs Conventional therapyP = 0.64

Serious adverse events: DKA and severe hypoglycaemia

No statistically significant differences in risk of DKA and severe hypoglycemia

Original publication

Efficacy and safety of hybrid closed-loop systems in children aged < 7 years with type 1 diabetes: a systematic review and meta-analysis of randomized controlled trials. Pediatr Diabetes. Published 12 August 2026. doi:10.48130/pedi-0026-0006

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.